L. Davis

PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer.

M. Augustus, F. Mostofi, V. Srikantan, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Allelic loss on chromosome 6Q in primary prostate cancer

F. Mostofi, V. Srikantan, J. Moul, 1999, International journal of cancer.

RNA interference–mediated cyclooxygenase-2 inhibition prevents prostate cancer cell growth and induces differentiation: modulation of neuronal protein synaptophysin, cyclin D1, and androgen receptor

L. Davis, N. Narayanan, Dominick Nargi, 2006, Molecular Cancer Therapeutics.

Androgen receptor mutation (T877A) promotes prostate cancer cell growth and cell survival

S. Srivastava, Y. Shi, D. Mcleod, 2006, Oncogene.

Programmed cell death as a new target for prostatic cancer therapy.

N. Kyprianou, J. Isaacs, L. Davis, 1991, Cancer surveys.

p63 expression profile in normal and malignant prostate epithelial cells.

Wei Zhang, J. Rhim, J. Moul, 2002, Anticancer Research.